BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34499036)

  • 1. Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD).
    Szabo-Reed AN; Hall T; Vidoni ED; Van Sciver A; Sewell M; Burns JM; Cullum CM; Gahan WP; Hynan LS; Kerwin DR; Rossetti H; Stowe AM; Vongpatanasin W; Zhu DC; Zhang R; Keller JN; Binder EF
    Alzheimers Dement (N Y); 2023; 9(4):e12422. PubMed ID: 37841653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment strategies for reaching adults aged 50 years and older with low socioeconomic status for participation in online physical activity interventions.
    Collombon EHGM; Bolman CAW; de Bruijn GJ; Peels DA; Lechner L
    Front Digit Health; 2024; 6():1335713. PubMed ID: 38800097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involving people with type 2 diabetes in facilitating participation in a cardiovascular screening programme.
    Dahl M; Søndergaard SF; Diederichsen A; Søndergaard J; Thilsing T; Lindholt JS
    Health Expect; 2021 Jun; 24(3):880-891. PubMed ID: 33761174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Web Portal for Communicating Polygenic Risk Score Results for Health Care Use-The P5 Study.
    Marjonen H; Marttila M; Paajanen T; Vornanen M; Brunfeldt M; Joensuu A; Halmesvaara O; Aro K; Alanne-Kinnunen M; Jousilahti P; Borodulin K; Koskinen S; Tuomi T; Ilanne-Parikka P; Lindström J; Laine MK; Auro K; Kääriäinen H; Perola M; Kristiansson K
    Front Genet; 2021; 12():763159. PubMed ID: 34777479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferred sources of information on diabetes prevention programmes: a population-based cross-sectional study in Poland.
    Grudziąż-Sękowska J; Sękowski K; Pinkas J; Jankowski M
    BMJ Open; 2024 May; 14(5):e083362. PubMed ID: 38760035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public Expectations and Needs Related to Type 2 Diabetes Prevention: A Population-Based Cross-Sectional Study in Poland.
    Grudziąż-Sękowska J; Sękowski K; Pinkas J; Jankowski M
    Int J Public Health; 2024; 69():1606790. PubMed ID: 38322305
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials.
    Kumar NB; Bahl S; Dhillon J; Poch M; Manley B; Li R; Schell M; Powsang J
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness of digital and group-based lifestyle interventions as compared with usual care to reduce type 2 diabetes risk - A stop diabetes pragmatic randomised trial.
    Lakka TA; Aittola K; Järvelä-Reijonen E; Tilles-Tirkkonen T; Männikkö R; Lintu N; Karhunen L; Kolehmainen M; Harjumaa M; Mattila E; Järvenpää R; Ermes M; Mikkonen S; Martikainen J; Poutanen K; Schwab U; Absetz P; Lindström J; Pihlajamäki J
    Lancet Reg Health Eur; 2023 Jan; 24():100527. PubMed ID: 36620354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study.
    Jalkanen K; Järvenpää R; Tilles-Tirkkonen T; Martikainen J; Aarnio E; Männikkö R; Rantala E; Karhunen L; Kolehmainen M; Harjumaa M; Poutanen K; Ermes M; Absetz P; Schwab U; Lakka T; Pihlajamäki J; Lindström J;
    JMIR Diabetes; 2021 Sep; 6(3):e21356. PubMed ID: 34499036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitally supported program for type 2 diabetes risk identification and risk reduction in real-world setting: protocol for the StopDia model and randomized controlled trial.
    Pihlajamäki J; Männikkö R; Tilles-Tirkkonen T; Karhunen L; Kolehmainen M; Schwab U; Lintu N; Paananen J; Järvenpää R; Harjumaa M; Martikainen J; Kohl J; Poutanen K; Ermes M; Absetz P; Lindström J; Lakka TA;
    BMC Public Health; 2019 Mar; 19(1):255. PubMed ID: 30823909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis.
    Jalkanen K; Aarnio E; Lavikainen P; Lindström J; Peltonen M; Laatikainen T; Martikainen J
    BMC Health Serv Res; 2021 Sep; 21(1):916. PubMed ID: 34482831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digitally Supported Lifestyle Intervention to Prevent Type 2 Diabetes Through Healthy Habits: Secondary Analysis of Long-Term User Engagement Trajectories in a Randomized Controlled Trial.
    Lavikainen P; Mattila E; Absetz P; Harjumaa M; Lindström J; Järvelä-Reijonen E; Aittola K; Männikkö R; Tilles-Tirkkonen T; Lintu N; Lakka T; van Gils M; Pihlajamäki J; Martikainen J
    J Med Internet Res; 2022 Feb; 24(2):e31530. PubMed ID: 35200147
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.